Roy D. Mugerwa
Roy D. Mugerwa publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as Tuberculosis Research and Epidemiology, Pneumocystis jirovecii pneumonia detection and treatment and Mycobacterium research and diagnosis.
- World rank
- #541,490 of 7,710,434 ranked researchers
- Rank in Uganda
- #229 of 3,724
- Works
- 110
- Citations
- 7.6k
- Citations per work
- 69.5
What does Roy D. Mugerwa research?
Roy D. Mugerwa's work is mostly in Medicine (67%), Immunology and Microbiology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7366.7%
- Medicine7366.7%
- Everything else2119.5%
- Life Sciences1513.8%
- Immunology and Microbiology1513.8%
- 1Infectious Diseases28% of their works
- 2Epidemiology23% of their works
- 3Surgery12% of their works
- 4Virology8% of their works
- 5Immunology5% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment
- Mycobacterium research and diagnosis
- HIV Research and Treatment
- Infectious Diseases and Tuberculosis
- Diagnosis and treatment of tuberculosis
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Which keywords describe Roy D. Mugerwa's research?
The keywords of their largest research topics: Diagnosis, Epidemiology, Antiretroviral Therapy, Immune Response, Vaccine, Drug Resistance, Mycobacterium tuberculosis and Tuberculosis.
- Nucleoside Analogues
- Preexposure Prophylaxis
- Diagnostic Challenges
- Tuberculous Meningitis
- Antibodies
- Nontuberculous Mycobacteria
- HIV Infection
- Pneumocystis
- Tuberculosis
- Drug Resistance
- Immune Response
- Epidemiology
- Diagnosis
- Antiretroviral Therapy
- Vaccine
- Mycobacterium tuberculosis
- HIV
- Pneumonia
- Mycobacterium avium
- AIDS
- Spinal Epidural Abscess
- Abdominal Tuberculosis
- HIV Transmission
- Integrase Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Diagnosis1313 topics
- Epidemiology1313 topics
- Antiretroviral Therapy1025 topics
- Immune Response922 topics
- Vaccine922 topics
- Drug Resistance752 topics
- Mycobacterium tuberculosis671 topic
- Tuberculosis671 topic
- HIV612 topics
- Pneumocystis361 topic
- Pneumonia361 topic
- HIV Infection292 topics
- Mycobacterium avium281 topic
- Nontuberculous Mycobacteria281 topic
- AIDS251 topic
- Antibodies251 topic
- Spinal Epidural Abscess211 topic
- Tuberculous Meningitis211 topic
- Abdominal Tuberculosis131 topic
- Diagnostic Challenges131 topic
- HIV Transmission121 topic
- Preexposure Prophylaxis121 topic
- Integrase Inhibitors81 topic
- Nucleoside Analogues81 topic
Where does Roy D. Mugerwa work?
Roy D. Mugerwa's main affiliation in the publication record is Makerere University, Uganda.
How many publications and citations does Roy D. Mugerwa have?
OpenAlex counts 110 works and 7,646 citations for Roy D. Mugerwa, an h-index of 44, ranking #541,490 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Roy D. Mugerwa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.